Where does Apnimed's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Apnimed's 8 recorded funding rounds.

Premier Alternatives

Apnimed

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of a pharmacologic therapy designed to target orally dosed medicines, the key underlying neurobiological mechanisms that lead to airway obstruction. Apnimed is based in Cambridge, MA and was founded in 2017. It was valued at $434 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $434 million across 8 recorded rounds; the latest was a $25 million early-stage round in Mar 2026.

PMV mark · valuation

$434.0M

Oct 2026

Priced at

its later-stage round

Mar 2026

Total raised

$434.3M

Last round

Early Stage VC

Mar 2026

Cap table — not yet on record

Apnimed's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Apnimed with a free account

·Watch Apnimed: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Apnimed

Where does Apnimed's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Apnimed's 8 recorded funding rounds.